Development of a novel multiplex PCR assay to detect functional subtypes of KIR3DL1 alleles

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Boudreau, Jeanette E ^a   Le Luduec, Jean Benoît ^a   Hsu, Katharine C ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; HLA B ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; KIR3DL1 PROTEIN, HUMAN;

ALLELE; ALLOTYPE; ARTICLE; CHILD; CONTROLLED STUDY; EXON; FLOW CYTOMETRY; GENE FREQUENCY; GENE IDENTIFICATION; GENE SEGREGATION; GENE SEQUENCE; HUMAN; HUMAN CELL; KIR3DL1 GENE; MEASUREMENT ACCURACY; MULTIPLEX POLYMERASE CHAIN REACTION; NATURAL KILLER CELL; PROCESS OPTIMIZATION; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; UNRELATED DONORS; VALIDATION PROCESS; GENETICS; PROCEDURES;

ALLELES; HUMANS; KILLER CELLS, NATURAL; MULTIPLEX POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, KIR3DL1;

EID: 84903388764     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099543     Document Type: Article

References (34)

1. Brodin P, Kärre K, Höglund P (2009) NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol 30: 143-149.
2. Hsu KC, Liu X-R, Selvakumar A, Mickelson E, O'Reilly RJ, et al. (2002) Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 169: 5118-5129. (Pubitemid 35217181)
3. Lanier LL (2005) NK cell recognition. Ann Rev Immunol 23: 225-274.
4. Anfossi N, André P, Guia S, Falk CS, Roetynck S, et al. (2006) Human NK cell education by inhibitory receptors for MHC Class I. Immunity 25: 331-342. (Pubitemid 44224147)
5. Kim S, Sunwoo JB, Yang L, Choi T, Song Y-J, et al. (2008) HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc Natl Acad Sci USA 105: 3053-3058. (Pubitemid 351723666)
6. Yu J, Heller G, Chewning J, Kim S, Yokoyama WM, et al. (2007) Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. J Immunol 179: 5977-5989.
7. Bonaparte MI, Barker E (2004) Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules. Blood 104: 2087-2094. (Pubitemid 39297862)
8. Martin MP, Qi Y, Gao X, Yamada E, Martin JN, et al. (2007) Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 39: 733-740. (Pubitemid 46848586)
9. Ruggeri L, Mancusi A, Capanni M, Urbani E, Carotti A, et al. (2007) Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. Blood 110: 433-440. (Pubitemid 47026866)
10. Hollenbach JA, Ladner MB, Saeteurn K, Taylor KD, Mei L, et al. (2009) Susceptibility to Crohn's disease is mediated by KIR2DL2/KIR2DL3 heterozygosity and the HLA-C ligand. Immunogenetics 61: 663-671.
11. Tarek N, Le Luduec J, Gallagher MM, Zheng J, Venstrom JM, et al. (2012) Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment. J Clin Invest 122: 3260.
12. Parham P, Norman PJ, Abi-Rached L, Guethlein LA (2011) Variable NK Cell receptors exemplified by human KIR3DL1/S1. J Immunol 187: 11-19.
13. Gardiner CM, Guethlein LA, Shilling HG, Pando M, Carr WH, et al. (2001) Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J Immunol 166: 2992-3001. (Pubitemid 33117294)
14. Yawata M, Yawata N, Draghi M, Little A-M, Partheniou F, et al. (2006) Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 203: 633-645.
15. Pando MJ, Gardiner CM, Gleimer M, Mcqueen KL, Parham P (2003) The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. J Immunol 171: 6640-6649. (Pubitemid 37532096)
16. Pascal V, Yamada E, Martin MP, Alter G, Altfeld M, et al. (2007) Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infection. J Immunol 179: 1625-1633.
17. Trundley A, Frebel H, Jones D, Chang C, Trowsdale J (2007) Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies. Eur J Immunol 37: 780-787. (Pubitemid 46916944)
18. Gagne K, Willem C, Legrand N, Djaoud Z, David G, et al. (2013) Both the nature of KIR3DL1 alleles and the KIR3DL1/S1 allele combination affect the KIR3DL1 NK-cell repertoire in the French population. Eur J Immunol 43: 1085-1098.
19. Norman PJ, Abi-Rached L, Gendzekhadze K, Korbel D, Gleimer M, et al. (2007) Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nature genetics 39: 1092-1099. (Pubitemid 47340657)
20. Carr WH, Pando MJ, Parham P (2005) KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J Immunol 175: 5222-5229. (Pubitemid 41456407)
21. O'Connor GM, Guinan KJ, Cunningham RT, Middleton D, Parham P, et al. (2007) Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. J Immunol 178: 235-241. (Pubitemid 46033606)
22. Vierra-Green C, Roe D, Hou L, Hurley CK, Rajalingam R, et al. (2012) Allele-Level haplotype frequencies and pairwise linkage disequilibrium for 14 KIR Loci in 506 European-American individuals. PLoS ONE 7: e47491.
23. Vilches C, Castaño J, Gómez-Lozano N, Estefanía E (2007) Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments. Tissue Antigens 70: 415-422. (Pubitemid 47537402)
24. Venstrom JM, Pittari G, Gooley TA, Chewning JH, Spellman S, et al. (2012) HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1. New Engl J Med 367: 805-816.
25. Sharma D, Bastard K, Guethlein LA, Norman PJ, Yawata N, et al. (2009) Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402. J Immunol 183: 4569-4582.
26. Halfpenny I, Middleton D, Barnett YA, Williams F (2004) Investigation of killer cell immunoglobulin-like receptor gene diversity: IV. KIR3DL1/S1. Hum Immunol 65: 602-612. (Pubitemid 38813411)
27. Sun JY, Oki A, Senitzer D (2008) Alleles and intron polymorphism of KIR3DL1 shown by combination of allele group-specific primers and sequencing. Tissue Antigens 72: 578-580.
28. Martin MP, Bashirova A, Traherne J, Trowsdale J, Carrington M (2003) Cutting Edge: Expansion of the KIR Locus by Unequal Crossing Over. J Immunol 171: 2192-2195. (Pubitemid 37025523)
29. Jiang W, Johnson C, Jayaraman J, Simecek N, Noble J, et al. (2012) Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors. Genome Research 22: 1845-1854.
30. Lebedeva TV, Ohashi M, Zannelli G, Cullen R, Yu N (2007) Comprehensive approach to high-resolution KIR typing. HIM 68: 789-796. (Pubitemid 47379985)
31. O'Connor GM, McVicar D (2013) The yin-yang of KIR3DL1/S1: molecular mechanisms and cellular function. Crit Rev Immunol 33: 203-218.
32. O'Connor GM, Vivian JP, Widjaja JM, Bridgeman JS, Gostick E, et al. (2014) Mutational and Structural Analysis of KIR3DL1 Reveals a Lineage-Defining Allotypic Dimorphism That Impacts Both HLA and Peptide Sensitivity. J Immunol 192: 2875-2884.
33. Thomas R, Yamada E, Alter G, Martin MP, Bashirova AA, et al. (2008) Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation? J Immunol 180: 6743-6750.
34. Keating PJ, Cromme FV, Duggan-Keen M, Snijders PJ, Walboomers JM, et al. (1995) Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression. Br J Cancer 72: 405-411.